Accéder au contenu
Merck

Dyskinesia detection and monitoring by a single sensor in patients with Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society (2015-07-17)
Giovanna Lopane, Sabato Mellone, Lorenzo Chiari, Pietro Cortelli, Giovanna Calandra-Buonaura, Manuela Contin
RÉSUMÉ

In current clinical practice, assessment of levodopa-induced dyskinesias (LIDs) in Parkinson's disease (PD) is based on semiquantitative scales or patients' diaries. We aimed to assess the feasibility, clinical validity, and usability of a waist-worn inertial sensor for discriminating between LIDs and physiological sway in both supervised and unsupervised settings. Forty-six PD patients on L-dopa therapy, 18 de novo PD patients, and 18 healthy controls were enrolled. Patients underwent clinical assessment of motor signs and dyskinesias and kinetic-dynamic L-dopa monitoring, tracked by serial measurements of plasma drug concentrations and motor and postural tests. A subset of features was selected, which showed excellent reliability. Sensitivity and specificity of the selected features for dyskinesia recognition were assessed in both supervised and unsupervised settings with an accuracy of 95% and 86%, respectively. Our preliminary findings suggest that it is feasible to design a reliable sensor-based application for dyskinesia monitoring at home.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Diisopropylamide de lithium solution, 2.0 M in THF/heptane/ethylbenzene
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Diisopropylamide de lithium solution, 1.0 M in THF/hexanes
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Lithium diisopropylamide, 97%
Référence
Conditionnement
Disponibilité
Prix
Quantité